GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Noul Co Ltd (XKRX:376930) » Definitions » Net Income From Continuing Operations

Noul Co (XKRX:376930) Net Income From Continuing Operations : ₩-16,543 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Noul Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Noul Co's net income from continuing operations for the three months ended in Mar. 2024 was ₩-3,922 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-16,543 Mil.

Noul Co Net Income From Continuing Operations Historical Data

The historical data trend for Noul Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noul Co Net Income From Continuing Operations Chart

Noul Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
-5,988.92 -8,973.33 -12,313.09 -13,680.02 -16,321.08

Noul Co Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,700.53 -3,664.99 -4,656.61 -4,298.96 -3,922.26

Noul Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-16,543 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noul Co (XKRX:376930) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Noul Co Ltd (XKRX:376930) » Definitions » Net Income From Continuing Operations
Comparable Companies
XKRX:180400 XKRX:038290 XKRX:153710 XKRX:051980 XKRX:950200 XKRX:363250 XKRX:122310 XKRX:253840 XKRX:086040 XKRX:245620 TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH
Traded in Other Exchanges
N/A
Address
B-10F, 338, Gwanggyojungang-ro, Suji-gu, Gyeonggi-do, Yongin-si, KOR, 16942
Website
https://www.noul.kr
Noul Co Ltd provides solutions for chronic and systemic problems in healthcare. The company's miLab is an all-in-one, fully-automated device which can process sample preparation and AI diagnostic in one workflow. It integrates technologies from computer vision AI, bio, hardware, and software engineering.

Noul Co (XKRX:376930) Headlines

No Headlines